CoinWhisperer
A

Acme Universal Safezone 9

ClosedSME
Open
28 Sep
2026
Close
30 Sep
2026
Allotment
1 Oct
2026
Listing
6 Oct
2026
Price band
₹65.00-71.00
Issue size
₹35.93 Cr
GMP
+₹16 (+22.54%)
Subscription
16.71x
GMP history
+22.5%30 Oct12 Nov

Grey-market premium (% of issue price) since we began tracking this IPO. GMP is unofficial and volatile.

Issue breakup
● Fresh issue 100%
₹36 Cr fresh. Fresh issue raises new capital for the company; OFS is existing shareholders selling their stake.
Subscription by category
CategorySubscription
Total16.71x
Lot size
ApplicationLotsSharesAmount
Individual investors (IND) (Min)23200₹2,27,200
Individual investors (IND) (Max)23200₹2,27,200
S-HNI (Min)34800₹3,40,800
S-HNI (Max)812800₹9,08,800
B-HNI (Min)914400₹10,22,400
Registrar
Maashitla Securities
Handles share allotment, refunds and the demat credit for this IPO.
About the company

Updated on Nov 1, 2026 Incorporated in November 2016, Acme Universal Safezone 9 Limited operates in the Personal Protective Equipment (PPE) segment, focusing on industrial safety footwear for sectors including construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemical processing, foundry and power generation. It offers 15 product lines across EVA-rubber, Nitrile Rubber and PVC sole types, providing protection against impact, compression, penetration, electrical shock, static electricity, heat and fire, chemicals and slipping. The Company operates four manufacturing facilities across Madhya Pradesh and Uttar Pradesh. It uses ICad3D technology for product design and visualisation and SAP S/4 HANA for enterprise resource planning across finance, operations and logistics.

Read the Acme Universal Safezone 9 RHP (prospectus)

Check allotment status →

Aggregated by CoinWhisperer for convenience. Figures (GMP, subscription, price band) can change and may be delayed - always verify on the official source and with your broker before applying. Do your own research.

← More IPOs on CoinWhisperer

Guides · About · Privacy · Terms · Contact · Sign in

Follow us on